GENERALIZED LIPODYSTROPHY
Clinical trials for GENERALIZED LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for GENERALIZED LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare fat disorder: drug trial targets blood sugar and fat levels
Disease control Recruiting nowThis study tests a new drug, mibavademab, in people with generalized lipodystrophy, a rare condition where the body lacks fat tissue. The goal is to see if the drug can improve blood sugar and fat levels. About 28 children and adults will take part in this Phase 3 trial, which co…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:11 UTC
-
New hope for toddlers with rare fat-loss disease as drug trial begins
Disease control Recruiting nowThis study tests a drug called metreleptin in children under 6 who have generalized lipodystrophy, a rare condition where the body loses fat tissue, leading to severe diabetes and high blood fats. The goal is to see if the drug safely lowers blood sugar and fat levels. About 15 c…
Matched conditions: GENERALIZED LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Amryt Pharma • Aim: Disease control
Last updated May 17, 2026 02:59 UTC